Deep Track Capital, LP Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001856083
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q2 2026 · 66 positions · Total reported value $6.72B · Top-10 concentration 40.5% · Updated 2026-10-24
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
Turnover: 59.3% · 18 new · 15 cut · 15 exited
Active Share (vs S&P 500): 100.0% · vs QQQ: 99.9% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q1 2026 → Q2 2026): +27.7% · vs SPY +12.9% · Prev Value $6.12B — last quarter positions weighted by this quarter price moves · ranking
In its Q2 2026 13F filing, Deep Track Capital, LP disclosed 66 equity positions with a combined reported value of $6.72B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 40.5% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.
The largest disclosed positions as of Q2 2026 were GH ($509.10M), IMVT ($359.91M), GPCR ($254.40M). By sector, the heaviest allocations are Health Care 95.4%, Other 4.6%. Versus the prior quarter, allocation shifted toward Health Care (+26.2pp) and away from Other (-26.2pp).
Versus the prior quarter, Deep Track Capital, LP opened 18 new positions, trimmed 15 and fully exited 15, a turnover rate of 59.3% of positions. The portfolio's overlap with the prior quarter was 59% of names.
The largest new positions opened in Q2 2026 were ALNY ($248.35M), COAG ($132.30M), GHRS ($89.60M).
Of the 15 positions fully exited versus the prior quarter, the largest were XBI ($1.28B), APLS ($182.34M), CNTA ($125.44M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q2 2026)
Fully Exited (vs previous quarter)
- XBI STATE STREET SPDR S&P BIOTECH ETF · prev qtr: $1.28B
- APLS APELLIS PHARMACEUTICALS INC · prev qtr: $182.34M
- CNTA CENTESSA PHARMACEUTICALS PLC · prev qtr: $125.44M
- BBIO BRIDGEBIO PHARMA INC · prev qtr: $62.49M
- TERN TERNS PHARMACEUTICALS INC · prev qtr: $56.61M
- GERN GERON CORP · prev qtr: $47.26M
- ANIP ANI PHARMACEUTICALS INC · prev qtr: $46.14M
- SLNO SOLENO THERAPEUTICS INC · prev qtr: $36.12M
Insider Transactions (Form 4)
Latest Deep Track Capital, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
| Transaction date | Activity | Security | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-08-06 | Conversion | Attovia Therapeutics, Inc. | 1,957,138 | — | SEC filing |
Fund Profile
Deep Track Capital, LP is an SEC-registered 13F filer based in Greenwich, CT, United States. As of Q2 2026 it reported 66 US equity positions with a combined value of $6.72B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Firm Snapshot
- Headquarters: GREENWICH, CT, United States
- SEC registration: 801-120500 (status: Approved), registered 2021-03-12
- Regulatory AUM (Form ADV): $8.37B as of 2026-03-31
- Client mix (by RAUM): pension and profit-sharing plans 100%
- Manages 2 private funds, of which 2 hedge funds
- Website: deeptrackcapital.com
Portfolio Structure
- 66 positions · $6.72B reported value (Q2 2026)
- Top 10 holdings = 40.5% of reported value
- Largest position: GH (GUARDANT HEALTH INC) at 7.6%
- Average position size: $101.75M
Sector Tilt
- Health Care 95.4%
- (classified holdings cover 95% of value)
Quarterly Activity
- Q2 2026: 18 new, 20 added, 15 reduced, 15 exited
- 13 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
3.39M | $509.10M | 7.58% | Add | |
| 2 |
|
9.34M | $359.91M | 5.36% | Reduce | |
| 3 |
|
4.74M | $254.40M | 3.79% | Add | |
| 4 |
|
4.30M | $249.96M | 3.72% | Hold | |
| 5 |
|
825.00K | $248.35M | 3.70% | New | |
| 6 |
|
2.00M | $245.88M | 3.66% | Add | |
| 7 |
|
3.67M | $230.79M | 3.44% | Add | |
| 8 |
|
1.78M | $220.24M | 3.28% | Add | |
| 9 |
|
4.00M | $209.58M | 3.12% | Add | |
| 10 |
|
19.69M | $193.32M | 2.88% | Hold | |
| 11 |
|
3.31M | $189.25M | 2.82% | Add | |
| 12 |
|
7.74M | $187.69M | 2.79% | Add | |
| 13 |
|
1.93M | $183.30M | 2.73% | Reduce | |
| 14 |
|
6.35M | $178.65M | 2.66% | Reduce | |
| 15 |
|
2.20M | $174.44M | 2.60% | Add | |
| 16 |
|
12.16M | $172.09M | 2.56% | Hold | |
| 17 |
|
4.00M | $171.64M | 2.56% | Reduce | |
| 18 |
|
700.00K | $171.34M | 2.55% | Reduce | |
| 19 |
|
7.00M | $136.27M | 2.03% | Add | |
| 20 |
|
3.60M | $132.30M | 1.97% | New | |
| 21 |
|
4.20M | $131.29M | 1.96% | Add | |
| 22 |
|
2.75M | $129.36M | 1.93% | Reduce | |
| 23 |
|
1.83M | $125.27M | 1.86% | Add | |
| 24 |
|
4.10M | $121.73M | 1.81% | Add | |
| 25 |
|
3.73M | $111.38M | 1.66% | Add | |
| 26 |
|
2.94M | $109.37M | 1.63% | Add | |
| 27 |
|
3.35M | $108.82M | 1.62% | Hold | |
| 28 |
|
1.73M | $95.64M | 1.42% | Reduce | |
| 29 |
|
3.33M | $89.60M | 1.33% | New | |
| 30 |
|
3.00M | $82.41M | 1.23% | Reduce | |
| 31 |
|
2.00M | $77.40M | 1.15% | Add | |
| 32 |
|
14.42M | $75.98M | 1.13% | Add | |
| 33 |
|
123.62K | $66.98M | 1.00% | New | |
| 34 |
|
3.61M | $66.71M | 0.99% | New | |
| 35 |
|
3.59M | $66.00M | 0.98% | Add | |
| 36 |
|
700.00K | $59.63M | 0.89% | Reduce | |
| 37 |
|
19.25M | $58.52M | 0.87% | New | |
| 38 |
|
4.00M | $53.60M | 0.80% | Add | |
| 39 |
|
9.35M | $49.44M | 0.74% | Hold | |
| 40 |
|
6.27M | $49.25M | 0.73% | Hold | |
| 41 |
|
700.00K | $48.05M | 0.72% | New | |
| 42 |
|
969.00K | $41.15M | 0.61% | New | |
| 43 |
|
2.49M | $37.23M | 0.55% | Hold | |
| 44 |
|
3.57M | $35.61M | 0.53% | Hold | |
| 45 |
|
1.00M | $34.32M | 0.51% | Add | |
| 46 |
|
1.50M | $33.31M | 0.50% | Reduce | |
| 47 |
|
2.77M | $28.61M | 0.43% | New | |
| 48 |
|
5.88M | $27.45M | 0.41% | Reduce | |
| 49 |
|
3.71M | $25.72M | 0.38% | New | |
| 50 |
|
6.00M | $25.56M | 0.38% | New | |
Loading forecast…
Holdings Prediction Model
Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.
The next-quarter predicted Top 10 (2026-Q3) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.
Latest-Quarter Accuracy (2026-Q2)
P 60% R 60% F1 60% (modelled on 2026-Q1; 6/10 hit)
Historical Backtest (10 quarters)
Avg precision 69% · recall 69% · F1 69% · avg rank error 3.2 · Top-10 turnover 32%
| Quarter | Prec. | Recall | F1 | Predicted Top 10 | Actual Top 10 |
|---|---|---|---|---|---|
| 2024-Q1 | 40% | 40% | 40% | INSM · SWTX · GH · ITCI · ARGX · ALKS · PLRX · DVAX · VRDN · AXSM | SWTX · AMGN · APGE · INSM · DYN · ALNY · GH · ARGX · NTLA · OCUL |
| 2024-Q2 | 80% | 80% | 80% | SWTX · AMGN · APGE · DYN · NTLA · GH · OCUL · INSM · ALNY · ARGX | AMGN · ARGX · AXSM · DYN · SWTX · INSM · GH · DVAX · ALNY · NTLA |
| 2024-Q3 | 70% | 70% | 70% | AMGN · ARGX · AXSM · DYN · SWTX · GH · DVAX · INSM · NTLA · ITCI | ARGX · DVAX · GH · APLS · IMVT · SWTX · DYN · ITCI · OCUL · NTLA |
| 2024-Q4 | 70% | 70% | 70% | ARGX · DVAX · APLS · IMVT · GH · ITCI · SWTX · DYN · OCUL · NTLA | DVAX · GH · ITCI · IMVT · APLS · SWTX · CYTK · OCUL · VRDN · PLRX |
| 2025-Q1 | 70% | 70% | 70% | DVAX · GH · ITCI · IMVT · APLS · CYTK · SWTX · OCUL · VRDN · GPCR | ITCI · GH · DVAX · IMVT · PTGX · IONS · AKRO · CYTK · APLS · OCUL |
| 2025-Q2 | 80% | 80% | 80% | ITCI · DVAX · GH · IMVT · PTGX · IONS · AKRO · CYTK · APLS · BBIO | GH · IONS · PTGX · DVAX · INSM · AKRO · IMVT · OCUL · APLS · CYTK |
| 2025-Q3 | 80% | 80% | 80% | IONS · GH · PTGX · INSM · AKRO · DVAX · IMVT · OCUL · APLS · CYTK | GH · IONS · CYTK · AKRO · APLS · TARS · IMVT · DVAX · OCUL · ETNB |
| 2025-Q4 | 60% | 60% | 60% | GH · CYTK · IONS · TARS · AKRO · APLS · IMVT · DVAX · ETNB · OCUL | XBI · IMVT · GH · GPCR · TARS · DVAX · CYTK · AXSM · APLS · PCVX |
| 2026-Q1 | 80% | 80% | 80% | XBI · IMVT · GPCR · GH · TARS · DVAX · AXSM · CYTK · PCVX · APLS | XBI · GH · IMVT · TARS · PCVX · GPCR · AXSM · APLS · OCUL · VERA |
| 2026-Q2 ★ | 60% | 60% | 60% | XBI · GH · IMVT · PCVX · TARS · GPCR · AXSM · OCUL · VERA · APLS | GH · IMVT · GPCR · PCVX · ALNY · MANE · TARS · NUVL · ALKS · OCUL |
★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.
FAQ
What did Deep Track Capital, LP buy in 2026-Q2?
In its 2026-Q2 13F filing, Deep Track Capital, LP reported 66 equity positions worth $6.72B in aggregate; its largest disclosed positions were GH ($509.10M), IMVT ($359.91M), GPCR ($254.40M).
How large is Deep Track Capital, LP's portfolio?
Deep Track Capital, LP reported $6.72B of long equity holdings across 66 positions as of 2026-Q2. Top-10 holdings account for 40.5% of reported value.
What is Deep Track Capital, LP's investment style?
HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.